Source document or public record
FDA 510(k) K231214 — LIAISON VZV IgG HT, LIAISON Control VZV IgG HT
FDA 510(k) index record K231214. Device: LIAISON VZV IgG HT, LIAISON Control VZV IgG HT. Applicant as listed: DiaSorin, Inc.. Decision date: 2023-10-27.
Source
"device_name": "LIAISON VZV IgG HT, LIAISON Control VZV IgG HT"
This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.
Review and references
Automated FDA record verification
2026-10-20
2026-10-20
professional use
FDA 510(k) public index record K231214.
Device name: LIAISON VZV IgG HT, LIAISON Control VZV IgG HT. Applicant as listed: DiaSorin, Inc..
Decision date: 2023-10-27. Decision wording: Substantially Equivalent.
Product code: LFY. Regulation: 21 CFR 866.3900. Medical specialty: Microbiology.
This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.
Interested in these solutions?
Submit a sourcing request with the assays, volumes, and timeline of your own project.